Sibannac, Inc. (SNNC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sibannac, Inc. (SNNC) trades at $0.01 with AI Score 63/100 (Grade B+). Sibannac, Inc. Market cap: $154,375, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for SNNC: SNNC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SNNC against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SNNC: 3/4 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Sibannac, Inc. (SNNC) Healthcare & Pipeline Overview
Sibannac, Inc. is a Phoenix-based provider of comprehensive media and business management solutions, encompassing online marketing, financial accounting, and regulatory compliance tools for enterprises. Concurrently, it operates within the cannabis sector, developing and marketing cannabinoid-based products, navigating an evolving regulatory landscape as an OTC-listed entity with a relatively small market capitalization.
What Is the Investment Thesis for SNNC?
Sibannac, Inc. presents a unique investment profile, operating across two distinct yet potentially synergistic sectors: comprehensive media and business management solutions, and the emerging cannabis market. The company's involvement in cannabinoid-based products positions it to capitalize on the growing consumer interest in alternative wellness, a market segment experiencing significant expansion. Its business management services, which include online marketing, financial accounting, and regulatory compliance tools, address critical needs for enterprises, potentially providing a stable revenue base. However, the company's financial metrics indicate significant challenges, including a negative profit margin of -3484.6% and a low gross margin of 2.7%, reflecting operational inefficiencies or early-stage investment. The market capitalization of 154K and an employee count of one underscore its micro-cap, speculative nature. As an OTC Other listed entity, SNNC is subject to the inherent volatility and liquidity challenges of over-the-counter markets. Investors may want to evaluate the high beta of 1.38, indicating greater price sensitivity than the broader market. Future performance hinges on successful market penetration in the cannabis sector, effective scaling of its business solutions, and navigating the complex and evolving regulatory landscape for cannabinoid products, alongside securing adequate funding to support growth initiatives.
Based on FMP financials and quantitative analysis
SNNC Key Highlights
- Market capitalization of 154K, indicating a micro-cap and highly speculative valuation.
- Profit margin of -3484.6%, reflecting significant operational losses.
- Gross margin of 2.7%, suggesting very low profitability from core operations.
- Beta of 1.38, indicating higher volatility compared to the broader market.
- Operates with 1 employee, suggesting a highly lean or outsourced operational model.
Who Are SNNC's Competitors?
SNNC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.34M | 63 |
| CAMRF Camurus AB (publ) | $60.00 | -1.66% | $3.60B | 63 |
| ITCI ITCI | $131.87 | +0.00% | $14.05B | 63 |
| CPHRF Cipher Pharmaceuticals Inc. | $11.94 | +1.49% | $303.17M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SNNC's Key Strengths?
- Diversified service offerings spanning business management and cannabinoid products.
- Focus on regulatory compliance, addressing a critical need for enterprises.
- Presence in the growing alternative wellness and cannabis product market.
- Integrated systems for comprehensive business administration.
What Are SNNC's Weaknesses?
- Negative profit margin (-3484.6%) and low gross margin (2.7%) indicating financial challenges.
- Extremely small operational scale with only one employee.
- OTC Other listing, implying limited transparency and market liquidity.
- Market capitalization of 154K, suggesting a highly speculative valuation.
What Could Drive SNNC Stock Higher?
- Potential positive regulatory developments or federal legalization initiatives impacting the cannabis sector, which could expand market access for cannabinoid products.
- Efforts to secure additional funding or strategic investments that could support operational expansion and product development for Sibannac, Inc.
- Successful expansion of market share for its cannabinoid-based products through enhanced distribution or new product launches.
- Introduction of new, specialized business management solutions that gain significant client adoption and generate new revenue streams.
What Are the Key Risks for SNNC?
- Financial-distress signal — its Altman Z-Score of -13.45 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- The highly volatile and evolving regulatory landscape surrounding cannabis, posing compliance challenges and market uncertainties for cannabinoid products.
- Inherent volatility and limited liquidity associated with trading on the OTC Other market, potentially leading to significant price fluctuations and difficulty in trading shares.
- Inability to secure adequate funding to support ongoing operations, product development, and market expansion initiatives, given the company's current financial profile.
- Sustained negative profit margin of -3484.6% and a low gross margin of 2.7%, indicating significant operational inefficiencies or early-stage losses that may persist.
- Intense competition from more established companies in both the business management solutions and the cannabis product sectors, potentially limiting market penetration.
What Are the Growth Opportunities for SNNC?
- Expansion in Cannabinoid Product Market: The growing consumer interest in alternative wellness products, particularly those containing cannabinoids, presents a significant growth avenue for Sibannac, Inc. The global cannabis market is projected to expand substantially, driven by increasing legalization and shifting consumer preferences towards natural remedies and wellness solutions. Sibannac's focus on developing and marketing cannabinoid-based products allows it to capture a share of this expanding market. Success in this area would involve expanding product lines, enhancing distribution channels, and effectively navigating the evolving regulatory landscape to gain market acceptance and scale operations over the next 3-5 years.
- Enhanced Business Management Solutions: There is an ongoing demand for specialized business management solutions, particularly those focused on online marketing, financial accounting, and regulatory compliance. Enterprises across various sectors continually seek efficient tools to streamline operations, improve financial oversight, and ensure adherence to complex industry regulations. Sibannac's suite of services directly addresses these needs. By continuously innovating and expanding its offerings, such as integrating AI-driven analytics or cloud-based platforms, the company can attract a broader client base and secure recurring revenue streams. This growth opportunity is ongoing, driven by the perennial need for operational efficiency and compliance.
- Strategic Partnerships and Acquisitions: Given its lean operational structure and small market capitalization, Sibannac, Inc. could pursue strategic partnerships or targeted acquisitions to accelerate growth. Collaborating with established players in either the cannabis industry (for distribution or product development) or the business solutions sector (for technology integration or client access) could provide access to new markets, resources, and expertise. Such alliances could mitigate some of the challenges associated with being an OTC-listed entity and a small-scale operator. This strategy could unfold over the next 2-4 years, contingent on identifying suitable partners and securing necessary funding.
- Leveraging Regulatory Clarity in Cannabis: The evolving regulatory landscape surrounding cannabis, while currently a risk, also presents a significant growth opportunity. As more regions clarify and liberalize cannabis laws, the market for cannabinoid-based products is expected to become more formalized and accessible. Sibannac, Inc. could strategically position itself to capitalize on these changes, potentially expanding into newly regulated markets or developing products that meet emerging compliance standards. Proactive engagement with regulatory developments and a flexible business model could enable the company to gain a competitive advantage as the industry matures over the next 5-10 years.
- Digital Marketing and Advertising Services Expansion: The digital transformation across industries has intensified the need for effective online marketing and advertising campaigns. Businesses of all sizes are increasingly investing in digital channels to reach customers, build brands, and drive sales. Sibannac's expertise in online marketing strategies and advertising campaigns positions it to capitalize on this trend. By offering specialized, data-driven digital marketing services tailored to specific industry niches, the company can expand its client portfolio and increase service revenue. This opportunity is ongoing, driven by the continuous evolution of digital platforms and consumer online behavior.
What Opportunities Does SNNC Have?
- Expansion within the rapidly growing global cannabis and cannabinoid product market.
- Increasing demand for specialized online marketing and business compliance solutions.
- Potential for strategic partnerships or acquisitions to scale operations and market reach.
- Benefiting from clearer regulatory frameworks as the cannabis industry matures.
What Threats Does SNNC Face?
- Highly volatile and evolving regulatory landscape in the cannabis sector.
- Intense competition from established players in both business solutions and cannabis markets.
- Challenges in securing adequate funding for growth and operational stability.
- Inherent risks associated with OTC-listed securities, including price volatility and limited investor interest.
What Are SNNC's Competitive Advantages?
- Specialized focus on integrated systems for regulatory compliance within complex industry environments.
- Dual business model combining business solutions with a presence in the emerging cannabis sector.
- Expertise in online marketing and advertising strategies tailored for enterprise clients.
- Agility and lean operational structure, potentially enabling rapid adaptation to market changes.
What Does SNNC Do?
Sibannac, Inc., headquartered in Phoenix, Arizona, operates as a dual-focused entity providing both comprehensive media and business management solutions and engaging in the cannabis sector. The firm offers enterprises a robust suite of services designed to enhance operational efficiency and ensure regulatory adherence. These services include sophisticated online marketing strategies, targeted advertising campaigns, and meticulous sales performance monitoring, crucial for businesses aiming to expand their digital footprint and optimize revenue generation. Furthermore, Sibannac delivers expert management consulting, providing strategic guidance to businesses navigating complex market environments and aiming for sustainable growth. Beyond these core offerings, the company integrates specialized systems for financial accounting, meticulous expenditure oversight, and streamlined workforce administration, all tailored to assist businesses in maintaining regulatory compliance within their respective industries, a critical need in today's intricate business landscape. In parallel, Sibannac, Inc. has established a presence in the evolving cannabis sector, focusing on the development and marketing of cannabinoid-based products. This segment positions the company within the broader alternative wellness market, which has seen growing consumer interest in products containing cannabinoids for various applications. This diversification allows Sibannac to tap into distinct market opportunities, leveraging potential synergies in marketing and distribution, particularly within regulated environments. As an OTC Other listed company, Sibannac's market position is characterized by its relatively small scale and speculative nature, reflecting the early-stage and high-growth potential, alongside inherent risks, of the cannabis industry. The company’s strategic focus on both compliance-driven business solutions and a high-growth consumer product segment underscores its approach to navigating dynamic market conditions. The operational structure, with a stated employee count of one, suggests a lean model, potentially relying on outsourced services or a highly specialized core team to manage its diverse offerings and navigate the complexities of both business management solutions and the cannabis product market from its Phoenix base.
What Products and Services Does SNNC Offer?
- Provides online marketing strategies for businesses.
- Develops and executes advertising campaigns.
- Monitors and analyzes sales performance for enterprises.
- Offers expert management consulting services.
- Delivers integrated systems for financial accounting.
- Manages expenditure oversight for businesses.
- Administers workforce management solutions.
- Develops and markets cannabinoid-based products within the wellness sector.
How Does SNNC Make Money?
- Generates revenue through service fees for providing media and business management solutions to enterprises.
- Derives income from the sale and marketing of cannabinoid-based products.
- Focuses on assisting businesses with regulatory compliance through specialized tools and consulting.
- Aims to capitalize on growing consumer interest in alternative wellness products.
What Industry Does SNNC Operate In?
Sibannac, Inc. operates within the broader Healthcare sector, specifically categorized under "Drug Manufacturers - Specialty & Generic," yet its business model extends significantly into business services. The company's engagement in the cannabis sector, developing and marketing cannabinoid-based products, positions it within a rapidly evolving segment of the specialty drug and wellness market. This segment is characterized by significant innovation, evolving regulatory frameworks, and increasing consumer adoption of alternative wellness solutions. Concurrently, its provision of media and business management solutions places it within the competitive landscape of professional services, where demand for online marketing, financial accounting, and regulatory compliance tools remains robust across various industries. Sibannac's dual focus allows it to tap into distinct market trends, but also exposes it to diverse competitive pressures. Its status as an OTC Other listed company with a minimal market capitalization suggests a niche or early-stage player within these industries, facing established competitors and the need to differentiate through specialized offerings or market agility.
Who Are SNNC's Key Customers?
- Small to medium-sized enterprises seeking comprehensive business management solutions.
- Businesses requiring online marketing, advertising, and sales performance monitoring services.
- Companies needing specialized financial accounting, expenditure oversight, and workforce administration systems.
- Consumers interested in cannabinoid-based wellness products.
Company Profile
Sibannac, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Phoenix, US. The company is led by CEO David A. Mersky. SNNC has traded publicly since 2014.
Sibannac, Inc. Financial Trajectory
Sibannac, Inc. (SNNC) reported $3K in revenue for Q1 2026, based on the latest filing compared to the prior quarter. The company recorded a net loss of $62K, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, SNNC averaged $-0.00 in diluted EPS.
How Sibannac, Inc. Is Valued
Sibannac, Inc. carries a market capitalization of 154K, placing it in the micro-cap category. Relative to its peer group, SNNC's quantitative score of 63/100 is roughly in line with the peer average of 67/100.
ROE 49%Key Financial Metrics
Return on equity for Sibannac, Inc. stands at 49.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -40.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -6.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -38.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
Sibannac, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.45 places it in the distress zone, a signal of elevated financial risk.
SNNC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying could signal confidence in SNNC's future prospects, suggesting those closest to the company believe it's undervalued.
- Positive chatter within the social trading community indicates growing optimism about SNNC's potential market position.
- The overall market perception of the cannabis sector seems to be improving, potentially lifting SNNC along with it.
- Recent developments suggest increased interest in SNNC's specific niche within the cannabis market, possibly driving future growth.
Bear Case
- Increased short selling activity might indicate institutional investors anticipate a price decline for SNNC.
- Negative sentiment circulating in social trading circles points to concerns about SNNC's ability to compete effectively.
- Recent market developments suggest heightened regulatory scrutiny within the cannabis industry, potentially impacting SNNC's operations.
- Despite positive sentiment, some community members express skepticism about SNNC's long-term viability due to market saturation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2,500 | -$62,111 | -$0.0005 |
| Q4 2025 | $0 | -$66,959 | -$0.0005 |
| Q3 2025 | $3,000 | -$93,668 | -$0.0008 |
| Q2 2025 | $3,413 | -$87,847 | -$0.0008 |
Based on FMP financials and quantitative analysis
SNNC Latest News
No recent news available for SNNC.
SNNC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SNNC.
Price Targets
Wall Street price target analysis for SNNC.
SNNC MoonshotScore
What does this score mean?
The MoonshotScore rates SNNC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David A. Mersky
President and Chief Executive Officer
David A. Mersky serves as the President and Chief Executive Officer of Sibannac, Inc. Details regarding Mr. Mersky's specific career history, educational background, and previous leadership roles prior to his tenure at Sibannac, Inc. are not publicly available within the provided source data. His professional credentials and the full scope of his experience leading organizations within the healthcare or business management sectors remain unknown.
Track Record: Information detailing specific key achievements, strategic decisions, or company milestones directly attributable to Mr. Mersky's leadership at Sibannac, Inc. is not provided in the available source data. The company's operational trajectory and any significant developments under his guidance are currently unknown.
SNNC OTC Market Information
Sibannac, Inc.'s classification as "OTC Other" signifies that it trades on the lowest tier of the OTC Markets Group's three marketplaces, below OTCQX and OTCQB. Companies in this tier typically do not meet the minimum disclosure standards for OTCQX or OTCQB, or they may choose not to provide current information. Unlike companies listed on major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements including minimum share prices, market capitalization, and regular SEC filings, OTC Other companies have significantly fewer regulatory obligations, leading to less transparency and higher risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and unknown disclosure status hinder informed investment decisions.
- Extreme price volatility and low liquidity due to trading on the OTC Other tier.
- Increased susceptibility to market manipulation given the lack of oversight and transparency.
- Difficulty in obtaining accurate and timely financial data for fundamental analysis.
- Potential for significant dilution from future capital raises in a less regulated environment.
- Verify any available financial statements directly from the company or third-party sources.
- Research management's background, experience, and track record beyond basic information.
- Assess the company's business model and competitive landscape thoroughly, given limited data.
- Investigate any regulatory actions or legal issues involving the company or its leadership.
- Examine the share structure, outstanding shares, and potential for future dilution.
- Understand the specific risks associated with the cannabis sector's regulatory environment.
- Evaluate the company's ability to secure funding and expand operations with limited resources.
- Clearly stated headquarters location in Phoenix, US.
- Identified CEO, David A. Mersky, despite limited background information.
- A defined business description outlining specific services and product focus.
- Presence in a recognized industry sector (Healthcare) and sub-industry (Drug Manufacturers).
SNNC Healthcare Stock FAQ
What does Sibannac, Inc. do?
Sibannac, Inc. operates with a dual business model, providing comprehensive media and business management solutions while also developing and marketing cannabinoid-based products. For enterprises, the company offers services such as online marketing strategies, advertising campaigns, sales performance monitoring, and expert management consulting. Additionally, it delivers integrated systems for financial accounting, expenditure oversight, and workforce administration, all designed to ensure regulatory compliance. In the cannabis sector, Sibannac focuses on capitalizing on growing consumer interest in alternative wellness products, positioning itself within the evolving market for cannabinoid solutions.
How does Sibannac, Inc. address the regulatory complexities of the cannabis sector?
Sibannac, Inc. operates within a cannabis sector characterized by an evolving and often complex regulatory landscape. While specific details on its regulatory approval processes or FDA/EMA track record are not provided, the company's business description emphasizes its provision of "specialized tools designed to assist businesses in maintaining regulatory compliance within complex industry environments." This suggests an internal focus on navigating compliance for its own operations and potentially for its clients. Its success in the cannabinoid product market is inherently tied to its ability to adapt to and comply with shifting state and federal regulations, which remains an ongoing risk and opportunity.
What are the financial implications of Sibannac, Inc.'s OTC Other listing?
Sibannac, Inc.'s OTC Other listing carries several financial implications for investors. This tier typically signifies lower disclosure requirements compared to major exchanges, resulting in an "Unknown" disclosure status and limited access to comprehensive financial reports. This lack of transparency can make accurate valuation and risk assessment challenging. Furthermore, OTC Other stocks often exhibit extremely low liquidity and wide bid-ask spreads, making it difficult to buy or sell shares efficiently without impacting the price. The inherent volatility of OTC-listed securities, combined with the company's 154K market cap and negative profit margin, contributes to a highly speculative investment profile.
What are Sibannac, Inc.'s primary revenue streams?
Sibannac, Inc. generates revenue from two primary business segments. Firstly, it earns income from providing a suite of comprehensive media and business management solutions to enterprises. This includes fees for services such as online marketing strategies, advertising campaigns, sales performance monitoring, management consulting, financial accounting systems, expenditure oversight, and workforce administration. Secondly, the company derives revenue from the development and marketing of cannabinoid-based products within the cannabis sector. The specific breakdown of revenue contribution from each segment is not provided, but both represent distinct avenues through which the company aims to generate sales and achieve profitability.
How does Sibannac, Inc. manage its operational efficiency with a single employee?
Sibannac, Inc.'s operational model, with a stated employee count of one, suggests a highly lean and potentially outsourced-dependent structure. While the exact details are not provided, it is common for such micro-cap companies, especially those in the OTC market, to leverage external contractors, consultants, and third-party service providers for specialized functions like marketing, product development, legal, and administrative tasks. The single employee, likely the CEO, would then focus on strategic oversight, business development, and managing these external relationships. This model can offer flexibility and reduced overhead but also introduces reliance on external parties and potential challenges in scaling operations.
What are the key factors to evaluate for SNNC?
Sibannac, Inc. (SNNC) holds an AI score of 63/100 (moderate). Not financial advice.
How frequently does SNNC data refresh on this page?
SNNC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SNNC's recent stock price performance?
Sibannac, Inc. (SNNC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings spanning business management and cannabinoid products. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is strictly limited to the provided source data. Specific details regarding CEO background, operational metrics, detailed financial breakdowns, and competitive landscape beyond general industry context are not available. The company's extremely small scale (1 employee, 154K market cap) and OTC Other listing imply significant data limitations and inherent speculative risks.